390 related articles for article (PubMed ID: 15375697)
1. Pseudomonas aeruginosa ExoS and ExoT.
Barbieri JT; Sun J
Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
[TBL] [Abstract][Full Text] [Related]
2. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
[TBL] [Abstract][Full Text] [Related]
3. Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements.
Brandt S; Shafikhani S; Balachandran P; Jin S; Hartig R; König W; Engel J; Backert S
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):190-205. PubMed ID: 17428306
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins.
Sun J; Barbieri JT
J Biol Chem; 2003 Aug; 278(35):32794-800. PubMed ID: 12807879
[TBL] [Abstract][Full Text] [Related]
5. How bacterial ADP-ribosylating toxins recognize substrates.
Sun J; Maresso AW; Kim JJ; Barbieri JT
Nat Struct Mol Biol; 2004 Sep; 11(9):868-76. PubMed ID: 15311272
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.
DiNovo AA; Schey KL; Vachon WS; McGuffie EM; Olson JC; Vincent TS
Biochemistry; 2006 Apr; 45(14):4664-73. PubMed ID: 16584201
[TBL] [Abstract][Full Text] [Related]
7. A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.
Zhang Y; Barbieri JT
Infect Immun; 2005 Dec; 73(12):7938-45. PubMed ID: 16299285
[TBL] [Abstract][Full Text] [Related]
8. Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.
Zhang Y; Deng Q; Porath JA; Williams CL; Pederson-Gulrud KJ; Barbieri JT
Cell Microbiol; 2007 Sep; 9(9):2192-201. PubMed ID: 17490406
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
Barbieri JT
Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
[TBL] [Abstract][Full Text] [Related]
10. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
[TBL] [Abstract][Full Text] [Related]
11. ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo.
Sundin C; Hallberg B; Forsberg A
FEMS Microbiol Lett; 2004 May; 234(1):87-91. PubMed ID: 15109724
[TBL] [Abstract][Full Text] [Related]
12. Role of Pseudomonas aeruginosa type III effectors in disease.
Engel J; Balachandran P
Curr Opin Microbiol; 2009 Feb; 12(1):61-6. PubMed ID: 19168385
[TBL] [Abstract][Full Text] [Related]
13. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
Maresso AW; Baldwin MR; Barbieri JT
J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
Maresso AW; Riese MJ; Barbieri JT
Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
[TBL] [Abstract][Full Text] [Related]
16. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
Rangel SM; Logan LK; Hauser AR
mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
[TBL] [Abstract][Full Text] [Related]
17. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
Sun J; Barbieri JT
J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
[TBL] [Abstract][Full Text] [Related]
18. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling Crk signal transduction by Pseudomonas exoenzyme T.
Deng Q; Sun J; Barbieri JT
J Biol Chem; 2005 Oct; 280(43):35953-60. PubMed ID: 16123042
[TBL] [Abstract][Full Text] [Related]
20. Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin.
Deng Q; Zhang Y; Barbieri JT
Traffic; 2007 Oct; 8(10):1331-45. PubMed ID: 17714437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
